General Information of the Compound
| Compound ID |
CP0427611
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(17-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaen-16-yl) (E)-3-(4-acetyloxy-3-methoxyphenyl)prop-2-enoate
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H29NO8
|
||||||||||||||||||
| Molecular Weight |
543.572
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2CC3N(CCc4cc5OCOc5cc34)Cc2c1OC(=O)\C=C\c1ccc(OC(C)=O)c(OC)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H29NO8/c1-18(33)39-25-7-4-19(12-27(25)36-3)5-9-30(34)40-31-23-16-32-11-10-21-14-28-29(38-17-37-28)15-22(21)24(32)13-20(23)6-8-26(31)35-2/h4-9,12,14-15,24H,10-11,13,16-17H2,1-3H3/b9-5+
Show/Hide
|
||||||||||||||||||
| InChIKey |
YGVKBBMLEFBXOS-WEVVVXLNSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01195, D(1A) dopamine receptor
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT01039, Tissue factor